New Publication: MADRAC Bulletin December 2015

User Rating: 1 / 5

Star ActiveStar InactiveStar InactiveStar InactiveStar Inactive
Bulletin MADRAC Dec 2015
Click the image to download/view MADRAC Bulletin – Dec 2015.


  • Succinylated Gelatin Intravenous Infusion Products - Summary of Safety Review in 2015
  • Amlodipine: Possible Risk of Blurred Vision
  • Cardiovascular Adverse Events Related to Diclofenac
  • Direct Healthcare Professional Communications (DHPCs) Reviewed and Approved by NPCB in 2015
  • Montelukast: Risk of Thrombocytopenia
  • Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: Risk of Severe Joint Pain
  • Fusafungine: Risk of Serious Allergic Reactions
  • New and Improved ADR Reporting Form (Blue Form)
  • ADR Reports Involving Anti-Tuberculosis Drugs
Click here for other issues of MADRAC Bulletin.


National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

  • Phone: +603-7883 5400




The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Site Last Modified

  • Last Modified: Saturday 20 July 2024, 01:25:04.
© Copyright 2023 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA


Main Menu English